Prelude Therapeutics Inc (NAS:PRLD)
$ 4.99 +0.080 (+1.63%) Market Cap: 397.43 Mil Enterprise Value: 333.60 Mil PE Ratio: 0 PB Ratio: 5.20 GF Score: 26/100

Prelude Therapeutics Inc (PRLD) Transcripts

  • 1